In MM, Gao et al. used IgG2a mAb mouse anti-human CD24 to treat myeloma cells in immunodeficient mice and showed the inhibition of multiple myeloma cell growth and the prevention of tumor progression [40]. Here, CD24 is linked to plasma cell myeloma.